SODINTEC FINANCES
De berekende faillissementskans van SODINTEC FINANCES over 12 maanden bedraagt 2,1% (gemiddeld). Het bedrijf is actief sinds 2014 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 11 jaar |
| Vestigingen | 1 |
| Publicaties | 1 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | volledig | 29-07-2025 | 2025-00334413 |
| 31-12-2023 | volledig | 27-06-2024 | 2024-00180953 |
| 31-12-2022 | volledig | 21-07-2023 | 2023-00269817 |
| 31-12-2021 | volledig | 29-07-2022 | 2022-20262065 |
| 31-12-2020 | volledig | 20-07-2021 | 2021-37400522 |
| 31-12-2019 | volledig | 27-10-2020 | 2020-66100131 |
| NACE primair | - |
| Rechtsvorm | BV(610) |
| Oprichtingsdatum | 22-12-2014 |
| Status | Actief |
| Postcode | 1200 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 21018A0083/00G000 | Brussel | 4.578 m² | 1 · 1.716 m² | 22,9 m · 7 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
08-06-2026 General meeting · Notarial deed · Auditor waiver · Auditor report
- Filing: 2026-05-28 · COLE PHARMACEUTICALS
- Publication: 2026-06-08 · COLE PHARMACEUTICALS
- General meeting: 2025-12-23 · COLE PHARMACEUTICALS
- Notarial deed: 2025-12-23 · COLE PHARMACEUTICALS
- Auditor waiver · COLE PHARMACEUTICALS
- Auditor report · COLE PHARMACEUTICALS
- Approval · COLE PHARMACEUTICALS
- Capital increase: amount: 1589000, currency: EUR, share_class: D, share_premium: 0, shares_issued: 659549 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 35088 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 2105 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 92184 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 90113 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 60172 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 111586 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 268301 · COLE PHARMACEUTICALS
- Statute amendment · COLE PHARMACEUTICALS
- Governance rule · COLE PHARMACEUTICALS
- Reserve release · COLE PHARMACEUTICALS
- Act object: Apports en nature - Modification des statuts
Technische details
{
"facts": [
{
"type": "filing",
"quote": "TRIBUNAL DE L\u0027ENTREPRISE 28 MAI 2026",
"value": "2026-05-28",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 08/06/2026 - Annexes du Moniteur belge",
"value": "2026-06-08",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "D\u0027un proc\u00E8s-verbal d\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire dress\u00E9 par le notaire Laurent WETS, \u00E0 Uccle, le 23 d\u00E9cembre 2025",
"value": "2025-12-23",
"object": null,
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "D\u0027un proc\u00E8s-verbal d\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire dress\u00E9 par le notaire Laurent WETS, \u00E0 Uccle, le 23 d\u00E9cembre 2025",
"value": "2025-12-23",
"object": "e2",
"subject": "e1"
},
{
"type": "auditor_waiver",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a dispens\u00E9 le Pr\u00E9sident de donner lecture du rapport \u00E9tabli par l\u0027organe d\u0027administration, le 15 d\u00E9cembre 2025",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "auditor_report",
"quote": "Le rapport du R\u00E9viseur d\u0027entreprises, Monsieur DEMONCEAU David, exer\u00E7ant sa fonction dans la Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u003C AXYLIUM AUDIT - LIEGE \u00BB",
"value": null,
"object": "e4",
"subject": "e1"
},
{
"type": "approval",
"quote": "L\u0027assembl\u00E9e a approuv\u00E9 ces deux rapports.",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "L\u0027op\u00E9ration consiste en une augmentation des capitaux propres de 1.589.000 \u20AC par apports de cr\u00E9ances et de droits de propri\u00E9t\u00E9 intellectuelle",
"value": {
"amount": 1589000,
"currency": "EUR",
"share_class": "D",
"share_premium": 0,
"shares_issued": 659549
},
"object": null,
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "1. A La Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u003C Sodintec Finances \u00BB, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, trente-cing mille quatre-vingt-huit actions, ci: 35.088",
"value": {
"class": "D",
"shares": 35088,
"consideration": {
"type": "cr\u00E9ances",
"amount": 60000,
"currency": "EUR"
}
},
"object": "e6",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "2. A La Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u00AB Spreds Finance \u003E, qui a d\u00E9clar\u00E9 accepter, deux mille cent cing cents actions, ci: 2.105",
"value": {
"class": "D",
"shares": 2105,
"consideration": {
"type": "cr\u00E9ances",
"amount": 4760,
"currency": "EUR"
}
},
"object": "e7",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "3. A la Soci\u00E9t\u00E9 Anonyme \u003C C\u0026N Holding \u00BB, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, nonante-deux mille cent quatre-vingt-quatre actions, ci: 92.184",
"value": {
"class": "D",
"shares": 92184,
"consideration": {
"type": "cr\u00E9ances",
"amount": 200000,
"currency": "EUR"
}
},
"object": "e8",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "4. A Monsieur DELEUZE St\u00E9phane, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, nonante mille cent treize actions, ci : 90.113",
"value": {
"class": "D",
"shares": 90113,
"consideration": {
"type": "cr\u00E9ances",
"amount": 200000,
"currency": "EUR"
}
},
"object": "e9",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "5. A Monsieur B\u00C9NARD Andr\u00E9, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, soixante mille cent soixante-deux actions, ci: 60.172",
"value": {
"class": "D",
"shares": 60172,
"consideration": {
"type": "cr\u00E9ances",
"amount": 150000,
"currency": "EUR"
}
},
"object": "e10",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "6. A Monsieur PHILIPS Mario, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, cent onze mille cing cent quatre-vingt-six (111.586) actions, ci: 111.586",
"value": {
"class": "D",
"shares": 111586,
"consideration": {
"type": "cr\u00E9ances",
"amount": 200000,
"currency": "EUR"
}
},
"object": "e11",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "7. A la Soci\u00E9t\u00E9 Anonyme Phytomed, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, deux cent soixante-huit mille trois cent une actions, ci: 268.301",
"value": {
"class": "D",
"shares": 268301,
"consideration": {
"type": "droits de propri\u00E9t\u00E9 intellectuelle",
"amount": 775000,
"currency": "EUR"
}
},
"object": "e12",
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9clar\u00E9 et d\u00E9cid\u00E9 de remplacer les articles 5, 7 et 11 des statuts par les textes suivants",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "governance_rule",
"quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de pr\u00E9voir, dans les statuts, la d\u00E9l\u00E9gation \u00E0 l\u0027organe d\u0027administration du pouvoir de proc\u00E9der, dans les limites des articles 5:142 et 5:143 dudit Code \u00E0 des distributions provenant du b\u00E9n\u00E9fice de l\u0027exercice en cours ou du b\u00E9n\u00E9fice de l\u0027exercice pr\u00E9c\u00E9dent tant que les comptes annuels de cet exercice n\u0027ont pas \u00E9t\u00E9 approuv\u00E9s",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "reserve_release",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de transf\u00E9rer la totalit\u00E9 des pertes report\u00E9es au compte apports disponibles.",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Apports en nature - Modification des statuts",
"value": "Apports en nature - Modification des statuts",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 18831,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0671.904.152",
"kind": "company",
"name": "COLE PHARMACEUTICALS",
"attrs": {
"vat": "BE0671.904.152",
"seat": "1435 Mont-Saint-Guibert, Rue Andr\u00E9 Dumont, 7",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e",
"short_name": "Cole Pharma"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Laurent WETS",
"attrs": {
"role": "notaire"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "V\u00E9ronique Bonehill",
"attrs": {
"role": "notaire"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "DEMONCEAU David",
"attrs": {
"role": "R\u00E9viseur d\u0027entreprises"
}
},
{
"id": "e5",
"kbo": null,
"kind": "org",
"name": "AXYLIUM AUDIT - LIEGE",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
}
},
{
"id": "e6",
"kbo": "0507.657.517",
"kind": "company",
"name": "Sodintec Finances",
"attrs": {
"vat": "BE0507.657.517",
"seat": "1200 Woluwe-Saint-Lambert Bruxelles, Rue Lola Bobesco, 2, bo\u00EEte 13",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
}
},
{
"id": "e7",
"kbo": "0538.839.354",
"kind": "company",
"name": "Spreds Finance",
"attrs": {
"vat": "BE0538.839.354",
"seat": "1000 Bruxelles, Rue des Colonies, 11",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
}
},
{
"id": "e8",
"kbo": "0866.337.880",
"kind": "company",
"name": "C\u0026N Holding",
"attrs": {
"vat": "BE0866.337.880",
"seat": "1910 Kampenhout, Terloonststraat, 22",
"legal_form": "Soci\u00E9t\u00E9 Anonyme"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "DELEUZE St\u00E9phane Camille Paul Arthur",
"attrs": {
"domicile": "London (Royaume-Uni-Grande Bretagne), Lawn Lane, 10, Apartment 1"
}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "B\u00C9NARD Andr\u00E9 Marcel Victor",
"attrs": {
"domicile": "Woluwe-Saint-Pierre (1150 Bruxelles), Avenue des Cormorans, 38"
}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "PHILIPS Mario",
"attrs": {
"domicile": "9340 Lede, Erfken, 6"
}
},
{
"id": "e12",
"kbo": "1031.897.777",
"kind": "company",
"name": "Phytomed",
"attrs": {
"vat": "BE 1031.897.777",
"seat": "9911 Troisvierges (Grand-Duch\u00E9 du Luxembourg), Rue de Drinklange, 2",
"rcs_lux": "B184202",
"legal_form": "Soci\u00E9t\u00E9 Anonyme de droit luxembourgeois"
}
}
]
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | SODINTEC FINANCES |